Good luck :-) [PK / PD]

posted by VijithRoy – India, 2020-07-30 14:59 (262 d 11:44 ago) – Posting: # 21806
Views: 1,572

Dear ElMaestro,

Thank you for your last reply with examples. really broadening up my mind.

» » The nurse and phlebotomist has the major pressure on them, since they are in the blood collection and subject monitoring process.'
»
» Plus the poor guy who is constantly screaming and kicking the YSI equipment. That guy will apply for early retirement after just a few trials, I guarantee it.

Hahaa, If that in case, I will be the one who will be applying for it. Because, since i am a trainee, i was handling YSI machines. (But happy that i never felt such hectic pressure i would say, may be as you said, after a few trials :-D)


So, Here we performing on Healthy male subjects under fasting condition, that so, is it mandatory for every generic drug (Eg - our insulin test and reference products) should conduct on under Healthy subjects under fasting condition ?

Is this study kind of assessing the dosage regimen, efficacy, ADR on Healthy subjects ?

Thank you in advance, Appreciate your reply.

With Best Regards,
Vroy.

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,509 registered users;
online 10 (0 registered, 10 guests [including 1 identified bots]).
Forum time: Monday 02:43 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5